Reviews
Every provider we cover, reviewed on the same published factors and openly scored by our AI editorial system — independent, evidence-based, and never influenced by who pays.
12 providers
DTC telehealth brand offering brand-name FDA-approved GLP-1s (Wegovy, Zepbound, Ozempic) plus insurance navigation and compounded options, with a membership fee charged separately from medication.
Membership $39 first month then $149/mo (or ~$74/mo prepaid annual, $888/yr); medication billed separately from ~$149/mo up to ~$299/mo (Zepbound), insurance may lower med cost.
Legacy behavioral weight-loss program (points + coaching) with a bolted-on GLP-1 telehealth track, 'WeightWatchers Clinic' (formerly Sequence), that prescribes FDA-approved brand-name GLP-1s and navigates insurance.
WW Clinic membership ~$74/mo ($25 first month on a 12-month plan); GLP-1 medication NOT included and billed separately (insurance-covered, or cash-pay ~$199-$1,200/mo).
Miami-based holistic GLP-1 telehealth membership bundling compounded semaglutide/tirzepatide with unlimited visits, dietitian, mental-health and fitness coaching for one flat monthly fee.
Compounded semaglutide from $249/mo month-to-month (as low as $150/mo annual); tirzepatide from $359/mo; oral tirzepatide from $389/mo; all-inclusive, no hidden fees.
Behavioral weight-loss app (psychology-based coaching) with a bolted-on GLP-1 telehealth track, 'Noom Med,' where compounded or branded medication is prescribed by partner clinicians and billed separately from the core coaching subscription.
Layered: core Noom coaching (~$70/mo) plus a Noom Med track - compounded-semaglutide plan ~$279/mo (med included); branded plan ~$99/mo telehealth fee with the drug purchased separately. Not a single flat compounded price.
DTC telehealth provider offering compounded and branded GLP-1 weight-loss medications on a flat month-to-month cash-pay subscription, shipped nationwide.
Cash-pay compounded semaglutide and tirzepatide; the brand publishes no price on its own site
Florida-based cash-pay telehealth service selling compounded semaglutide and tirzepatide in injection and oral form, plus a low-dose "microdose" line, with clinical care through OpenLoop and fulfilment by a named pharmacy — but no price published before checkout.
No price is published for the core GLP-1 treatments — every product variant on the site is listed at $0.00 and the figure appears only inside the intake and checkout. Two of the combination "microdose" products show $199/month.
Delaware-registered cash-pay telehealth aimed at women in midlife, selling compounded and branded GLP-1s, menopause hormone therapy and two longevity peptides — with a published price on every line and no named pharmacy or clinician on any of them.
A headline price is published before signup on all three lines: compounded GLP-1/GIP from $179/month on a yearly plan (the FAQ quotes $199/month on a three-month plan), branded Ozempic at $1,299/month, HRT from $69/month, and each longevity compound at $199/month for 28 days or $118/month on a 12-month plan.
Cash-pay compounded GLP-1 telehealth from Modern Metabolic Medicine, Inc., with the full price ladder published up front, four named dispensing pharmacies, and a strict no-refund policy under which the qualifying consultation happens after payment.
$69–$129/mo compounded, paid up front by term: semaglutide $79 (1mo) / $228 (3mo) / $438 (6mo) / $828 (12mo); tirzepatide $129 / $378 / $738 / $1,428. No separate membership fee.
DTC telehealth platform (Lean Rx, Inc., Sacramento CA) selling compounded semaglutide and tirzepatide in injectable, sublingual, and tablet forms with async provider review.
Telehealth weight-loss service offering low-cost compounded semaglutide and tirzepatide with mandatory live video visits and dietitian support, shadowed by a major safety scandal at its own compounding pharmacy.
$39 first month then $79/mo membership + $99 (compounded semaglutide) or $199 (compounded tirzepatide) per 4 weekly doses; ~$178-$278/mo all-in; branded GLP-1s via insurance
Cash-pay telehealth marketing brand selling compounded semaglutide and tirzepatide, with clinical care and compounding fully outsourced to third-party networks.
Price not verifiable — no retrievable figure from MEDVi, and its site is refused on terms
Cash-pay telehealth platform (Sprout Health Partners LLC, joinsprouthealth.com) selling compounded semaglutide and tirzepatide via async intake with no required labs.
$149-$299/mo compounded (semaglutide from ~$149-$249; tirzepatide from ~$199-$299); brand Wegovy $1,799 / Zepbound $1,999